News Release(2015)

November 26, 2015

Announcement of the Launch of "P-TOL® Chewable Tab." for the Treatment of Hyperphosphatemia in Japan

November 20, 2015

Kissei Announces Licensing Agreement with ObsEva SA for KLH-2109, a Novel Investigational Drug for the Treatment of Endometriosis

September 28, 2015

New Drug Application Approval for "P-TOL®Chewable Tablets" for the Treatment of Hyperphosphatemia in Japan

March 31, 2015

Kissei and Ajinomoto Pharmaceuticals announce partnership for joint development and marketing of AJM300 and AJG511 for treatment of ulcerative colitis in Japan

March 20, 2015

Kissei Pharmaceutical Co., Ltd. Receives Approval in Japan for Additional Indication and Dosage and Administration of DOPRAM® Injectable 400mg for Primary Apnea in Premature and Low-Birth-Weight Infants (Apneic Attack of Prematurity)